Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01957787 · ClinicalTrials.gov registry record · NA
Study of Cryoablation for Metastatic Lung Tumors
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT01957787 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 131 participants.
The verdict
NCT01957787, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of cryoablation therapy used to treat tumors in participants with pulmonary metastatic disease. This study is to enroll participants who will undergo cryoablation of at least 1 metastatic pulmonary tumor that is less than or equal to 3.5 centimeter (cm). Participants will be followed 24 months post their cryoablation procedure.
Interventions
- DEVICE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2014-04-10 |
| Est. Completion | 2018-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01957787
The ClinicalTrials.gov registry entry for NCT01957787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT01957787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01957787 about?
NCT01957787 is a clinical study titled "Study of Cryoablation for Metastatic Lung Tumors". The purpose of this study is to evaluate the safety and efficacy of cryoablation therapy used to treat tumors in participants with pulmonary metastatic disease. This study is to enroll participants who will undergo cryoablation of at least 1 metastatic pulmonary tumor that is less than or equal to 3...
What is the current status of trial NCT01957787?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2014-04-10. Estimated completion is 2018-08-20.
What interventions are being tested in trial NCT01957787?
The interventions under investigation include: Cryoablation (DEVICE).
Who is sponsoring clinical trial NCT01957787?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.